ReCode Therapeutics Competitors and Similar CompaniesClear all
ReCode Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, PTC Therapeutics, Verona Pharma, Breath Therapeutics, BillionToOne and Synspira.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that invests in scientific innovation to create medicines for people with cystic fibrosis. |  PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs. |  Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases. |  Breath Therapeutics Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases. |  BillionToOne BillionToOne is a precision diagnostics company offering a prenatal cystic fibrosis and spinal muscular atrophy screening option. |  Synspira Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases. | |
Founding Date | Founding Date 2015 | Founding Date 1989 | Founding Date 1998 | Founding Date N/A | Founding Date 2017 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||||
Locations | Locations Menlo Park, US HQ Dallas, US | Locations Boston, US HQ St Leonards, AU Wien, AT São Paulo, BR São Paulo, BR Toronto, CA Prague, CZ see more | Locations South Plainfield, US HQ | Locations London, GB HQ Cardiff, GB Raleigh, US | Locations Dieburg, DE HQ München, DE Cambridge, US | Locations Menlo Park, US HQ | Locations Framingham, US HQ |
Employees | Employees 1303% increase | Employees 3,90015% increase | Employees 75448% increase | Employees 33 | Employees N/A | Employees 3542% increase | Employees 8 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 90.5 b | Valuation ($) 1.6 b | Valuation ($) 293.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 384 | Twitter followers 71 k | Twitter followers 2.1 k | Twitter followers N/A | Twitter followers N/A | Twitter followers 602 | Twitter followers 64 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 34 | Number of tweets (last 30 days) 36 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 265.3 | Average likes per tweet (last 30 days) 3.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 5.3 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 83.33% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 5 | Employee Rating 4.2 | Employee Rating 4.1 | Employee Rating N/A | Employee Rating N/A | Employee Rating 4.2 | Employee Rating N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.9b (FY, 2022) | Revenue (est.) $698.8m (FY, 2022) | Revenue (est.) $458k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.1b (FY, 2022) | Cost of goods N/A | Cost of goods $346k (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $7.9b (FY, 2022) | Gross profit N/A | Gross profit $112k (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $3.3b (FY, 2022) | Net income ($559m) (FY, 2022) | Net income ($68.7m) (FY, 2022) | Net income N/A | Net income N/A | Net income N/A |
Operating ⚠ | |||||||
Products | Products N/A | Products 6 (FY, 2020) | Products N/A | Products N/A | Products N/A | Products 3 (Feb, 2023) | Products N/A |
Funding | |||||||
Latest funding round | Latest funding round $ 80m (over 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 55m (over 2 years ago) | Latest funding round $ 3m (almost 6 years ago) |
Total funding raised | Total funding raised $ 82m | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised $ 46m | Total funding raised $ 87.5m | Total funding raised $ 11.2m |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
3,900↑ 15% increase
Vertex Pharmaceuticals is a biotechnology company that invests in scientific innovation to create medicines for people with cystic fibrosis.
View companyPTC Therapeutics
HQ
South Plainfield, US
Employees
754↑ 48% increase
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
View companyVerona Pharma
HQ
London, GB
Employees
33
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
View companyBreath Therapeutics
HQ
Dieburg, DE
Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases.
View company